Evidence map›Paper›PMID 40726930›Full record

ReviewWorld journal of clinical cases2025

Hereditary alpha tryptasemia and clinical implications.

Ece Tüsüz Önata, Öner Özdemir, Süreyya Savaşan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ece Tüsüz ÖnataDivision of Allergy and Immunology, Department of Pediatrics, Sakarya Research and Training Hospital, Medical Faculty, Sakarya University, Sakarya 54100, Türkiye.
Öner ÖzdemirDivision of Allergy and Immunology, Department of Pediatrics, Sakarya Research and Training Hospital, Sakarya University, Faculty of Medicine, Sakarya 54100, Türkiye. onerozdemir@sakarya.edu.tr.
Süreyya SavaşanDepartment of Pediatrics, Central Michigan University College of Medicine, Mt Pleasant, MI 48859, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary alpha tryptasemia was first described in 2016 and is the most common (up to 72%) cause of elevated serum basal tryptase (TPS). The clinical presentation of this condition, which is caused by copy number gains in the

Indexed as

Autosomal dominantHereditary alpha tryptasemiaMast cellTryptasemiaTyrosine kinase protein

Identifiers

PMID40726930
PMCPMC12068170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.